Author: Crop Protection

When a government decides a deal won’t go through, a certain silence descends. There won’t be a press conference or an outright ban; instead, the regulator will wait a few weeks, ask for additional documents, and then wait a few more weeks. That’s how Beijing handled Meta’s $2 billion offer for Manus, the Chinese agentic AI startup that was one of the most anticipated names in the industry until recently. The agreement didn’t fall through in court. It was just left to suffocate. It’s difficult to ignore how well this aligns with Beijing’s other recent actions, which include discussing protecting…

There is a document in a federal records office somewhere that hardly anyone ever reads. For many years, the Handbook of Occupational Groups and Families has subtly regulated one of the most important issues in American civic life: what precisely does the government employ people to do? For the first time in what seems like a very long time, someone opened it last week and began crossing things out. The federal occupational handbook will no longer include 115 job titles, according to an announcement made by the Office of Personnel Management. Among those killed were “bowling equipment repairing,” “buffing and…

Something seems a little strange when you stroll down Fremont Street on a Tuesday afternoon. The neon continues to buzz. The slot machines continue to chime. However, a different image begins to emerge when you speak with the bartenders, hotel housekeepers, and construction workers eating lunch close to the Convention Center. They are quieter, more nervous, and more difficult to shake. According to textbook definitions, Las Vegas is not experiencing a recession in 2026. However, it also doesn’t feel totally stable. On paper, the metro area’s unemployment rate of 5.7 to 5.8 percent is not disastrous. Nevertheless, even a slight…

In markets, there is a specific type of moment that seldom makes an announcement. The bell doesn’t ring. There are no screaming headlines. The opportunity is already diminishing in the rearview mirror by the time most investors realize that the window is quietly closing. Dave Sekera, chief U.S. market strategist at Morningstar, has been pointing to one of those times, and it’s important to pay attention. The overall U.S. stock market has recovered significantly from its previous volatility as of late April 2026, and it is currently trading at about a 5% discount to Morningstar’s aggregate fair value estimate. That…

Millions of American homeowners did what seemed perfectly reasonable at the time: they stayed put for more than five years. Selling meant giving up all of that in order to reenter a market that was charging more than 6 percent. They had locked in mortgage rates around 3 percent, which now seem almost unreal. So they bided their time. and held out. Not because no one wanted to move, but rather because the math of moving was absurd, the housing market collapsed. Slowly and unevenly, that standoff seems to be ending. Housing analysts have been closely monitoring a recent shift…

Only investors in biotech seem to comprehend a certain kind of cruelty. After years of witnessing a company spend money on a truly challenging project, such as a medication that could potentially treat one of the most deadly cancers known to science, the data turns out to be more robust than anticipated, and the stock still plummets. That’s essentially what happened to Erasca in late April, and even by Wall Street’s notoriously callous standards, it was startling to watch. The main medication from Erasca, ERAS-0015, is a pan-RAS molecular glue that targets RAS-driven cancers, such as pancreatic cancer, which still…

These days, a “sleep concierge” may be waiting at the front desk of a boutique hotel in Manhattan, ready to inquire as to whether you would rather have your pillow filled with goose down or buckwheat. This would have sounded absurd a few years ago. It is now a selling point that has been photographed for Instagram and printed on the brochure. Somewhere along the line, rest evolved from something you just do to something you buy. It’s difficult to dispute the numbers. Due to a unique combination of wearable technology, wellness anxiety, and a wealthy class that believes sleep…

An email was the first clue that something wasn’t right. Somewhere off the coast of Singapore, a crew member sat down at a screen and typed out a complaint that would eventually end up on desks in Washington, London, and Mumbai. He was aboard a ship known as the Beeta. In actuality, it was the Gale, a tanker that the US had already placed on a blacklist. He was unpaid. There wasn’t much food left. In the midst of all of this, he made the risky and uncomfortable decision to be honest. That one email encapsulates, in miniature, the true…

Strangely, the story has aged. When He Jiankui announced he had altered the twin girls’ genomes on that Hong Kong stage in late 2018, the audience responded as they do when something irreversible has just occurred. First, be quiet. Then it was loud. Then loudly. After seven years, the questions remain, but the noise has subsided. They’ve actually gotten heavier. The twins’ pseudonyms, Lulu and Nana, are now school-age children in China. The one thing almost everyone agrees was done correctly is that their identities are still protected. Almost nothing is settled beyond that. He said that in order to…

The science isn’t the first thing you see when you enter the lab at Colossal Biosciences on the outskirts of Dallas. It’s theatrical. On a fictitious stone cliff, a life-size animatronic dire wolf scans an imaginary horizon by shifting its head every few seconds. A model mammoth is covered in a fog of dry ice. At the door, reporters’ phones are confiscated. It’s obvious that someone has given careful thought to what it would be like to walk into the future of biology. The fact is that it functions. Colossal has raised hundreds of millions of dollars and a valuation…